These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
824 related items for PubMed ID: 26117186
21. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J. Eur J Pharm Sci; 2013 Feb 14; 48(3):393-405. PubMed ID: 23266466 [Abstract] [Full Text] [Related]
22. Gastrointestinal delivery of anti-inflammatory nanoparticles. Laroui H, Sitaraman SV, Merlin D. Methods Enzymol; 2012 Feb 14; 509():101-25. PubMed ID: 22568903 [Abstract] [Full Text] [Related]
23. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy. Qi WW, Yu HY, Guo H, Lou J, Wang ZM, Liu P, Sapin-Minet A, Maincent P, Hong XC, Hu XM, Xiao YL. Mol Pharm; 2015 Mar 02; 12(3):675-83. PubMed ID: 25584860 [Abstract] [Full Text] [Related]
24. Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells. Jalilzadeh N, Samadi N, Salehi R, Dehghan G, Iranshahi M, Dadpour MR, Hamishehkar H. Sci Rep; 2020 Jan 31; 10(1):1606. PubMed ID: 32005894 [Abstract] [Full Text] [Related]
25. Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis. Yan Y, Sun Y, Wang P, Zhang R, Huo C, Gao T, Song C, Xing J, Dong Y. Carbohydr Polym; 2020 Oct 15; 246():116660. PubMed ID: 32747292 [Abstract] [Full Text] [Related]
28. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer. Xiao B, Viennois E, Chen Q, Wang L, Han MK, Zhang Y, Zhang Z, Kang Y, Wan Y, Merlin D. ACS Nano; 2018 Jun 26; 12(6):5253-5265. PubMed ID: 29860836 [Abstract] [Full Text] [Related]
29. Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles. Lim SM, Kim TH, Jiang HH, Park CW, Lee S, Chen X, Lee KC. Biomaterials; 2011 May 26; 32(13):3538-46. PubMed ID: 21306770 [Abstract] [Full Text] [Related]
30. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, Cheng X, Chen X. Int J Pharm; 2013 Nov 30; 457(1):158-67. PubMed ID: 24029170 [Abstract] [Full Text] [Related]
31. Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon. Marvola T, Marvola J, Kanerva H, Ahonen A, Lindevall K, Marvola M. Int J Pharm; 2008 Feb 12; 349(1-2):24-9. PubMed ID: 17869037 [Abstract] [Full Text] [Related]
32. The promoting effect of enteric materials on the oral absorption of larotaxel-loaded polymer-lipid hybrid nanoparticles. Gou J, Liang Y, Miao L, Chao Y, Zhang Y, Yin T, He H, Tang X. Eur J Pharm Sci; 2018 Nov 01; 124():288-294. PubMed ID: 30193858 [Abstract] [Full Text] [Related]
33. Entrapping of Nanoparticles in Yeast Cell Wall Microparticles for Macrophage-Targeted Oral Delivery of Cabazitaxel. Ren T, Gou J, Sun W, Tao X, Tan X, Wang P, Zhang Y, He H, Yin T, Tang X. Mol Pharm; 2018 Jul 02; 15(7):2870-2882. PubMed ID: 29863879 [Abstract] [Full Text] [Related]
35. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles. Esmaeili F, Dinarvand R, Ghahremani MH, Ostad SN, Esmaily H, Atyabi F. Anticancer Drugs; 2010 Jan 02; 21(1):43-52. PubMed ID: 19809300 [Abstract] [Full Text] [Related]
36. Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres. Keohane K, Rosa M, Coulter IS, Griffin BT. Drug Dev Ind Pharm; 2016 Jan 02; 42(2):245-53. PubMed ID: 26083078 [Abstract] [Full Text] [Related]
37. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease. Pertuit D, Moulari B, Betz T, Nadaradjane A, Neumann D, Ismaïli L, Refouvelet B, Pellequer Y, Lamprecht A. J Control Release; 2007 Nov 20; 123(3):211-8. PubMed ID: 17889397 [Abstract] [Full Text] [Related]
38. Influence of charge on encapsulation and release behavior of small molecules in self-assembled layer-by-layer microcapsules. Mandapalli PK, Labala S, Vanamala D, Koranglekar MP, Sakimalla LA, Venuganti VV. Drug Deliv; 2014 Dec 20; 21(8):605-14. PubMed ID: 24328418 [Abstract] [Full Text] [Related]
39. In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles. Hsieh WJ, Liang CJ, Chieh JJ, Wang SH, Lai IR, Chen JH, Chang FH, Tseng WK, Yang SY, Wu CC, Chen YL. Int J Nanomedicine; 2012 Dec 20; 7():2833-42. PubMed ID: 22745546 [Abstract] [Full Text] [Related]
40. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles. Chuah LH, Roberts CJ, Billa N, Abdullah S, Rosli R. Colloids Surf B Biointerfaces; 2014 Apr 01; 116():228-36. PubMed ID: 24486834 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]